Supplemental material
Future Oncology
Volume 20, 2024 - Issue 6
Open access
1,699
Views
0
CrossRef citations to date
0
Altmetric
Meta-Analysis
Association Between Event-Free Survival and Overall Survival in Early-Stage Triple-Negative Breast Cancer
Min Huang1 Merck & Co., Inc., Rahway, NJ, USACorrespondence[email protected]
, Peter A Fasching2 Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Department of Gynecology & Obstetrics, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany
, Amin Haiderali1 Merck & Co., Inc., Rahway, NJ, USA
https://orcid.org/0000-0002-6858-1564
Weiguang Xue3 Analysis Group, London, UK
https://orcid.org/0000-0003-0713-2869
Wilbur Pan1 Merck & Co., Inc., Rahway, NJ, USA
, Vassiliki Karantza1 Merck & Co., Inc., Rahway, NJ, USA
, Fan Yang3 Analysis Group, London, UK
, James Truscott3 Analysis Group, London, UK
, Yiqiao Xin3 Analysis Group, London, UK
& Joyce O’Shaughnessy4 Baylor University Medical Center, Texas Oncology & US Oncology, Dallas, TX, USA
show all
Pages 335-348
|
Received 12 Apr 2023, Accepted 01 Aug 2023, Published online: 21 Aug 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.